The Clinical Characteristics and Prognosis of 15 Patients with Psoriasis and Coronary Heart Disease
Author:
Affiliation:

Department of Cardiology, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, Jiangsu 210008, China)

Clc Number:

R758.63

  • Article
  • | |
  • Metrics
  • |
  • Reference [21]
  • | | | |
  • Comments
    Abstract:

    Aim To summarize the clinical characteristics and prognosis of psoriasis complicated with coronary heart disease (CHD). Methods A retrospective analysis was performed on 15 patients diagnosed with psoriasis and primary CHD by coronary angiography. The traditional CHD risk factors, the situation of the first cardiovascular event, the characteristics of coronary artery lesion and follow-up results of cardiovascular disease events and psoriasis were analyzed. Results The age of onset CHD in patients with psoriasis was 55.13±10.90 years old, and traditional risk factors for CHD were 3.20±1.01 average per case. There were 11 cases (73.33%) of acute coronary syndrome in 15 cases, including 5 cases of acute ST-segment elevation myocardial infarction, 3 cases of acute non ST-segment elevation myocardial infarction, 3 cases of unstable angina pectoris. Coronary angiography showed single vessel lesion in 4 cases (26.67%), double vessel lesion in 3 cases (20.0%) and three vessel lesion in 6 cases (40.0%), left main coronary artery lesion in 2 cases (13.33%), left main coronary artery lesion plus three vessel lesion in 1 case (6.67%). 11 cases (73.33%) were diffuse lesions, among them, 2 cases (13.33%) were diffuse lesion with severe calcification. Percutaneous coronary intervention (PCI) was administered in 11 patients. The average follow-up time was 16.33±8.65 months, and 3 patients had recurrent angina, 2 cases of them were treated with PCI again. Psoriasis area and severity index (PASI) score of 15 patients at the last follow-up was significantly lower than that at the admission (8.98±1.34 vs 12.91±1.10, P=0.01). Conclusions Patients with psoriasis and CHD are more acute onset. The degree of coronary artery lesion is heavy, and the incidence of cardiovascular events is higher during the follow-up period. The use of statins may also have a certain degree of improvement in the condition of psoriasis.

    Reference
    [1] 丁晓岚, 王婷琳, 沈佚葳, 等.中国六省市银屑病流行病学调查.中国皮肤性病学杂志, 0,4(7):598-601.
    [2] Gelfand JM, Neimann AL, Shin DB, et al.Risk of myocardial infarction in patients with psoriasis.J Am Med Assoc, 6,6(14):1 735-741.
    [3] 程燕, 陈小玫, 段茜, 等.银屑病患者罹患冠心病的风险评估.中华皮肤科杂志, 2,5(9):627-630.
    [4] 中国成人血脂异常防治指南制订联合委员会.中国成人血脂异常防治指南.中华心血管病杂志, 7,5(5):390-419.
    [5] Van de Kerkhof PC.The psoriasis area and severity index and alternative approaches for the assessment of severity:persisting areas of confusion.Br J Dermatol, 7,7(4):661-662.
    [6] Krueger JG, Bowcock A.Psoriasis pathophysiology:current concepts of pathogenesis.Ann Rheum Dis, 5,4(Suppl 2):30-36.
    [7] Armstrong AW, Voyles SV, Armstrong EJ, et al.A tale of two plaques:convergent mechanisms of T-cell-mediated inflammation in psoriasis and atherosclerosis.Exp Dermatol, 1,0(7):544-549.
    [8] Armstrong AW, Voyles SV, Armstrong EJ, et al.Angiogenesis and oxidative stress:common mechanisms linking psoriasis with atherosclerosis.J Dermatol Sci, 1,3(1):1-9.
    [9] Armstrong EJ, Harskamp CT, Armstrong AW.Psoriasis and major adverse cardiovascular events:a systematic review and meta-analysis of observational studies.J Am Heart Assoc, 3,2(2):e000 062.
    [10] Mosca S, Gargiulo P, Balato N, et al.Ischemic cardiovascular involvement in psoriasis:a systematic review.Int J Cardiol, 5,8:191-199.
    [11] Armstrong AW, Harskamp CT, Armstrong EJ.The association between psoriasis and hypertension:a systematic review and meta-analysis of observational studies.J Hypertens, 3,1(3):433-442.
    [12] Armstrong AW, Harskamp CT, Armstrong EJ.Psoriasis and the risk of diabetes mellitus:a systematic review and meta-analysis.JAMA Dermat, 3,9(1):84-91.
    [13] Ma C, Harskamp CT, Armstrong EJ, et al.The association between psoriasis and dyslipidaemia:a systematic review.Br J Dermatol, 3,8(3):486-495.
    [14] Armstrong AW, Harskamp CT, Armstrong EJ.The association between psoriasis and obesity:a systematic review and meta-analysis of observational studies.Nutr Diabetes, 2,2(10):e54.
    [15] Mizutani H, Ohmoto Y, Mizutani T, et al.Role of increased production of monocytes TNF-alpha, IL-1 beta and IL-6 in psoriasis:relation to focal infection, disease activity and responses to treatments.J Dermatol Sci, 7,4(2):145-153.
    [16] Libby P.Inflammation in atherosclerosis.Nature, 2,0(6917):868-874.
    [17] Ribatti D, Levi-Schaffer F, Kovanen PT.Inflammatory angiogenesis in atherogenesis--a double-edged sword.Ann Med, 8,0(8):606-621.
    [18] Mallbris L, Granath F, Hamsten A, et al.Psoriasis is associated with lipid abnormalities at the onset of skin disease.J Am Acad Dermatol, 6,4(4):614-621.
    [19] Shirinsky IV, Shirinsky VS.Efficacy of simvastatin in plaque psoriasis:A pilot study.J Am Acad Dermatol, 7,7(3):529-531.
    [20] Greenwood J, Steinman L, Zamvil SS.Statin therapy and autoimmune disease:from protein prenylation to immunomodulation.Nat Rev Immunol, 6,6(5):358-370.
    [21] Lebwohl M, Tyring SK, Hamilton TK, et al.A novel targeted T-cell modulator, efalizumab, for plaque psoriasis.New Engl J Med, 3,9(21):2 004-013.
    Related
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

WANG Kun, ZHANG Jing-Mei, LI Pei-Wen, WANG Lian, QIAO Jian-Zhong, GU Rong, XU Biao. The Clinical Characteristics and Prognosis of 15 Patients with Psoriasis and Coronary Heart Disease[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2016,24(11):1149-1152.

Copy
Share
Article Metrics
  • Abstract:939
  • PDF: 978
  • HTML: 0
  • Cited by: 0
History
  • Received:December 07,2015
  • Revised:January 04,2016
  • Online: December 02,2016
Article QR Code